TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,288 | -8.8% | 665 | -7.4% | 0.00% | 0.0% |
| Q2 2023 | $11,280 | +21.1% | 718 | +27.1% | 0.00% | +100.0% |
| Q1 2023 | $9,312 | +5.7% | 565 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8,814 | +25.9% | 565 | +12.3% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | -41.7% | 503 | -39.3% | 0.00% | -50.0% |
| Q2 2022 | $12,000 | 0.0% | 828 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $12,000 | +33.3% | 832 | +29.6% | 0.00% | +100.0% |
| Q4 2021 | $9,000 | -18.2% | 642 | -2.3% | 0.00% | -50.0% |
| Q3 2021 | $11,000 | +37.5% | 657 | +31.9% | 0.00% | +100.0% |
| Q2 2021 | $8,000 | -33.3% | 498 | -25.4% | 0.00% | -50.0% |
| Q1 2021 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $12,000 | +20.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | -23.1% | 668 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $13,000 | – | 668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |